Alison May, PhD
- ASSISTANT PROFESSOR | Cell, Developmental & Regenerative Biology
Research Topics:Aerodigestive Tract, Cell Biology, Cellular Differentiation, Computational Biology, Developmental Biology, Differentiation, Epigenetics, Epithelial Cells, Growth Factors and Receptors, Human Genetics and Genetic Disorders, Lung, Mucosal Immunology, Organogenesis, Stem Cells
Alison May, PhD, is an Assistant Professor of Cell, Developmental, and Regenerative Biology and Otolaryngology at the Icahn School of Medicine at Mount Sinai, and a member of the Black Family Stem Cell Institute and the Institute of Airway Sciences. Her research investigates exocrine organ development and stem cell-mediated regeneration of multiple epithelial tissues including the respiratory gland and salivary gland systems. She obtained her PhD at King's College London where she characterized the morphogenesis and temporal localization of the nasal and tracheal submucosal glands and identified gene regulators of their development. During her postdoctoral research training at the University of California, San Francisco she defined regulatory mechanisms of multiple independent cell populations in both embyronic and adult salivary glands, and defined nerve-epithelial interactions required for gland progenitor cell maintenance, specification and organ repair. Her current work aims to define causative mechanisms of upper airway disease, inclduing Cystic Fibrosis and Chronic Rhinosinusitis, through defining alterations in the structure and function of epithelial tissues.
May Lab website: https://labs.icahn.mssm.edu/maylab/
BA, Trinity College Dublin
PhD, King's College London
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. May did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.